Accretion Nutraveda Limited (BOM:544694)

Market Cap	2.07B
Revenue (ttm)	336.15M +5,645.6%
Net Income	50.68M
EPS	9.35
Shares Out	7.24M
PE Ratio	30.59
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,000
Open	292.95
Previous Close	277.00
Day's Range	286.00 - 292.95
52-Week Range	129.00 - 305.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Accretion Nutraveda

Accretion Nutraveda Limited manufactures and supplies ayurvedic, nutraceutical, and wellness formulations in India and internationally. The company offers nutraceuticals products, including formulation for brain, memory and neuron care, UTI care, cardiac care, liver care, protein supplement, pediatric care, git care, effervescent, joint and bone care, immunity booster, gynec care, hair, skin, nail care, and infertility and PCOS care. It also provides ayurvedic products for bone and joint, respiratory, gynec, aphrodisiac, skin, digestive, hair, ...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2021
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544694

Financial Performance

In fiscal year 2026, Accretion Nutraveda's revenue was 336.15 million, an increase of 110.07% compared to the previous year's 160.02 million. Earnings were 50.68 million, an increase of 102.66%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 22, 2026

Data Sources Report a data error